Immunome Inc (IMNM) stock news · rev $6.9M
Immunome Inc (IMNM) is a biotechnology company listed on US.
This IMNM news page leads with what Immunome Inc filed — not a scraped headline mill.
No cached 8-K sentence for IMNM yet. We will not pad this page with generic market recap.
Latest reported IMNM revenue for 2025-12-31 was $6.9M. Net income was -$212.4M. Revenue was down 23.2% from 2024-12-31 to 2025-12-31. IMNM currently screens at market cap $2.47B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the IMNM stock page; for the tape open the quote page.
IMNM stock news FAQ
What are IMNM's latest revenue and net income?
Latest cached Immunome Inc (IMNM) revenue for Dec 31, 2025 was $6.9M. Net income was -$212.4M. Statements: https://lician.com/financials/imnm
How did IMNM revenue change from the prior cached period?
Cached Immunome Inc (IMNM) revenue was down 23.2% from $9.0M (Dec 31, 2024) to $6.9M (Dec 31, 2025). Statements: https://lician.com/financials/imnm
What is IMNM's market cap?
Immunome Inc (IMNM) market cap is $2.47B on the latest cached fundamentals snapshot.
What kind of company is IMNM?
Immunome Inc (IMNM) is a biotechnology company listed on US.
Where is IMNM stock news listed?
Cached stock news for Immunome Inc (IMNM) is listed at https://lician.com/news/imnm. Filings: https://lician.com/sec/imnm
Not investment advice.